Alpharma To Pay $42.5M Over Morphine Marketing

By Erin Marie Daly

Law360, New York (March 16, 2010, 6:55 PM ET) -- Pharmaceutical giant Alpharma Inc. has agreed to fork over $42.5 million to resolve allegations that it paid health care providers to promote its morphine-based drug Kadian and misrepresented the medicine's safety.

The settlement, announced Tuesday by the U.S. Department of Justice, will be split between the federal government and several states, with the U.S. receiving roughly $33.6 million to resolve the federal claims and the states receiving approximately $8.9 million to settle their respective claims.

The deal resolves a 2006 lawsuit brought by Debra Parks under...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles